Detalhe da pesquisa
1.
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.
Cancer Immunol Immunother
; 73(7): 135, 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38758239
2.
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study.
Ann Hematol
; 2024 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38492020
3.
Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs.
Haematologica
; 108(12): 3399-3408, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470160
4.
Anti-CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study.
Hematol Oncol
; 41(3): 442-452, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433829
5.
Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis.
Eur J Haematol
; 110(4): 444-454, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597575
6.
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine.
Cancer Sci
; 112(12): 5034-5045, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34644446
7.
Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma.
Hematol Oncol
; 39(3): 349-357, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724498
8.
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis.
Eur J Haematol
; 106(4): 555-562, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476404
9.
[Treatment strategy for immunoglobulin light chain amyloidosis].
Rinsho Ketsueki
; 62(8): 1160-1166, 2021.
Artigo
em Japonês
| MEDLINE | ID: mdl-34497203
10.
Factors Associated with Dose Modification of Lenalidomide Plus Dexamethasone Therapy in Multiple Myeloma.
Biol Pharm Bull
; 43(8): 1253-1258, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32741946
11.
Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12).
Int J Clin Oncol
; 24(8): 966-975, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30937622
12.
[Spontaneous regression of primary gastric EBV-positive diffuse large B-cell lymphoma].
Rinsho Ketsueki
; 60(11): 1573-1576, 2019.
Artigo
em Japonês
| MEDLINE | ID: mdl-31839637
13.
[Successful treatment of relapse/refractory multiple myeloma with carfilzomib, lenalidomide, and dexamethasone combination therapy following allogeneic bone marrow transplantation].
Rinsho Ketsueki
; 60(10): 1468-1470, 2019.
Artigo
em Japonês
| MEDLINE | ID: mdl-31695009
14.
[Latent essential thrombocythemia becoming perceptible after splenectomy].
Rinsho Ketsueki
; 60(5): 387-391, 2019.
Artigo
em Japonês
| MEDLINE | ID: mdl-31168000
15.
The serum level of plasmin-alpha2 plasmin inhibitor complex (PIC) is useful for differentiating cardiac light chain amyloidosis from transthyretin amyloidosis.
Br J Haematol
; 202(6): 1209-1212, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37424146
16.
[Agranulocytosis during therapy of chronic myeloid leukemia lymphoid blast crisis with dasatinib].
Rinsho Ketsueki
; 59(11): 2438-2440, 2018.
Artigo
em Japonês
| MEDLINE | ID: mdl-30531140
17.
[Possible contribution of disseminated Mycobacterium shigaense infection to development of splenic marginal zone lymphoma].
Rinsho Ketsueki
; 59(7): 878-883, 2018.
Artigo
em Japonês
| MEDLINE | ID: mdl-30078797
18.
CEA-producing multiple myeloma with meningeal invasion during relapse.
Rinsho Ketsueki
; 58(5): 438-442, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28592756
19.
Renal artery stenosis following nilotinib administration in a patient with chronic myelogenous leukemia.
Rinsho Ketsueki
; 58(1): 15-19, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28190859
20.
Quincke's edema and hypersensitivity pneumonitis induced by lenalidomide for multiple myeloma.
Rinsho Ketsueki
; 57(12): 2502-2506, 2016.
Artigo
em Japonês
| MEDLINE | ID: mdl-28090017